X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Patent (484) 484
Journal Article (193) 193
Publication (33) 33
Newspaper Article (14) 14
Book / eBook (3) 3
Book Chapter (3) 3
Conference Proceeding (3) 3
Book Review (2) 2
Magazine Article (1) 1
Trade Publication Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
chemistry (473) 473
metallurgy (471) 471
organic chemistry (470) 470
human necessities (462) 462
hygiene (462) 462
medical or veterinary science (462) 462
peptides (459) 459
preparations for medical, dental, or toilet purposes (459) 459
specific therapeutic activity of chemical compounds ormedicinal preparations (294) 294
microbiology (179) 179
biochemistry (172) 172
beer (171) 171
enzymology (171) 171
mutation or genetic engineering (171) 171
spirits (171) 171
vinegar (171) 171
wine (171) 171
compositions thereof (169) 169
culture media (169) 169
microorganisms or enzymes (169) 169
propagating, preserving or maintaining microorganisms (169) 169
general tagging of cross-sectional technologies spanning over several sections of the ipc (165) 165
general tagging of new technological developments (165) 165
technical subjects covered by former uspc cross-reference art collections [xracs] and digests (165) 165
technologies for adaptation to climate change (165) 165
technologies or applications for mitigation or adaptation againstclimate change (165) 165
investigating or analysing materials by determining theirchemical or physical properties (100) 100
measuring (100) 100
physics (100) 100
testing (100) 100
humans (91) 91
index medicus (71) 71
fermentation or enzyme-using processes to synthesise a desiredchemical compound or composition or to separate optical isomersfrom a racemic mixture (68) 68
agriculture (59) 59
animal husbandry (59) 59
care of birds, fishes, insects (59) 59
fishing (59) 59
forestry (59) 59
hunting (59) 59
new breeds of animals (59) 59
rearing or breeding animals, not otherwise provided for (59) 59
trapping (59) 59
compositions or test papers therefor (44) 44
condition-responsive control in microbiological orenzymological processes (44) 44
measuring or testing processes involving enzymes, nucleicacids or microorganisms (44) 44
processes of preparing such compositions (44) 44
immunotherapy (41) 41
animals (40) 40
female (40) 40
immunology (39) 39
nucleotides (38) 38
derivatives thereof (36) 36
male (36) 36
nucleic acids (36) 36
nucleosides (36) 36
sugars (36) 36
cancer (35) 35
mice (32) 32
oncology (30) 30
adult (25) 25
melanoma (25) 25
dermatology (23) 23
middle aged (23) 23
antibodies, monoclonal - therapeutic use (20) 20
aged (19) 19
ipilimumab (19) 19
tumors (19) 19
care and treatment (17) 17
pd-1 (17) 17
psoriasis (17) 17
metastatic melanoma (16) 16
regulatory t-cells (16) 16
therapy (16) 16
antigens (15) 15
cell line, tumor (15) 15
article (14) 14
research (14) 14
drug therapy (13) 13
expression (13) 13
life sciences (13) 13
multidisciplinary sciences (13) 13
abridged index medicus (12) 12
ctla-4 (12) 12
ctla-4 blockade (12) 12
lymphocytes (12) 12
mice, inbred c57bl (12) 12
treatment outcome (12) 12
antibodies (11) 11
antibodies, monoclonal - immunology (11) 11
cell biology (11) 11
ligands (11) 11
programmed cell death 1 receptor - antagonists & inhibitors (11) 11
t cells (11) 11
antibodies, monoclonal - pharmacology (10) 10
dendritic cells (10) 10
immune response (10) 10
lymphocytes t (10) 10
monoclonal antibodies (10) 10
neoplasms - immunology (10) 10
prospective studies (10) 10
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (622) 622
French (124) 124
German (55) 55
Spanish (47) 47
Chinese (33) 33
Portuguese (18) 18
Korean (17) 17
Danish (8) 8
Norwegian (7) 7
Slovenian (7) 7
Japanese (6) 6
Greek (5) 5
Croatian (4) 4
Russian (4) 4
Polish (3) 3
Hungarian (2) 2
Italian (1) 1
Lithuanian (1) 1
Serbian (1) 1
Ukrainian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


PLoS ONE, ISSN 1932-6203, 06/2018, Volume 13, Issue 6, pp. e0198158 - e0198158
Expression of cytotoxic T-lymphocyte antigen 4 (CTLA-4), a negative regulator of T-cell function, is increased in chronic HIV-1 infection. It was hypothesized... 
TRIAL | METASTATIC MELANOMA | INFLAMMATION | MULTIDISCIPLINARY SCIENCES | IMMUNE ACTIVATION | ANTIRETROVIRAL THERAPY | CTLA-4 | INFECTION | T-CELL EXHAUSTION | UP-REGULATION | EXPRESSION | HIV Infections - virology | Humans | Middle Aged | Male | RNA, Viral - blood | CD4 Lymphocyte Count | Ipilimumab - adverse effects | Viremia - drug therapy | CTLA-4 Antigen - immunology | Dose-Response Relationship, Drug | HIV Infections - immunology | HIV-1 - immunology | Maximum Tolerated Dose | Adult | Female | HIV Infections - drug therapy | Viremia - immunology | CTLA-4 Antigen - antagonists & inhibitors | Ipilimumab - administration & dosage | Viremia - metabolism | HIV Infections - metabolism | Ipilimumab - pharmacokinetics | Safety and security measures | Immune response | Ipilimumab | HIV patients | Dosage and administration | Research | Drug therapy | Pharmacokinetics | Health aspects | HIV infection | Corticoids | Toxicity | Viremia | CD8 antigen | Chronic infection | Clinical trials | Cytotoxicity | Infections | Lymphocytes T | Metastasis | Hepatitis | CTLA-4 protein | Acquired immune deficiency syndrome--AIDS | Lymphocytes | Antiretroviral agents | Human immunodeficiency virus--HIV | Paralysis | Drug dosages | Antinuclear antibodies | Chronic illnesses | Immune system | Antigens | Corticosteroids | Research & development--R&D | Melanoma | Diarrhea | Pharmacology | Ribonucleic acid--RNA | Patients | Antiretroviral therapy | CD4 antigen | Viability | Viral infections | Index Medicus | RNA | Research & development | Acquired immune deficiency syndrome | Ribonucleic acid | AIDS | R&D | HIV | Human immunodeficiency virus
Journal Article
Cancer Research, ISSN 0008-5472, 09/2015, Volume 75, Issue 17, pp. 3466 - 3478
Journal Article
Cancer Research, ISSN 0008-5472, 07/2017, Volume 77, Issue 13 Supplement, pp. SY09-01 - SY09-01
Journal Article
Cancer Cell, ISSN 1535-6108, 10/2015, Volume 28, Issue 4, p. 543
Journal Article
Cancer Cell, ISSN 1535-6108, 09/2015, Volume 28, Issue 3, p. 285
Immune checkpoint blockade of the programmed cell death protein 1 (PD-1) pathway by monoclonal antibodies (Abs) has shown promising clinical benefit in the... 
Monoclonal antibodies | Tumors
Journal Article
Nature, ISSN 0028-0836, 11/2014, Volume 515, Issue 7528, pp. 577 - 581
Journal Article
Cancer Cell, ISSN 1535-6108, 06/2016, Volume 29, Issue 6, p. 820
While engagement of the inhibitory Fc[gamma]-receptor (Fc[gamma]R) IIB is an absolute requirement for in vivo antitumor activity of agonistic mouse anti-CD40... 
Analysis | Monoclonal antibodies | Health aspects
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 06/2012, Volume 366, Issue 26, pp. 2443 - 2454
Releasing T cells from inhibitory control has been a strategy exploited by the anti–CTLA-4 antibody ipilimumab. Now an antibody against a second checkpoint... 
CELL LUNG-CANCER | MEDICINE, GENERAL & INTERNAL | THERAPY | SOLID TUMORS | RESPONSE CRITERIA | IMMUNOTHERAPY | GUIDELINES | B7 FAMILY | B7-H1 | ANTITUMOR IMMUNITY | BLOCKADE | Neoplasms - metabolism | Antibodies, Monoclonal - pharmacology | Humans | Antibodies, Monoclonal - adverse effects | Programmed Cell Death 1 Receptor - metabolism | Antibodies, Monoclonal - therapeutic use | Male | Programmed Cell Death 1 Receptor - antagonists & inhibitors | Antineoplastic Agents - therapeutic use | Neoplasms - drug therapy | Dose-Response Relationship, Drug | Antineoplastic Agents - adverse effects | Colorectal Neoplasms - drug therapy | Melanoma - drug therapy | Adult | Female | Ligands | Antineoplastic Agents - pharmacology | Carcinoma, Non-Small-Cell Lung - drug therapy | Programmed Cell Death 1 Receptor - immunology | Carcinoma, Renal Cell - drug therapy | Prostatic Neoplasms - drug therapy | Drugs | Dose-response relationship (Biochemistry) | Immune response | Anti-antibodies | Dosage and administration | Product/Service Evaluations | Regulation | Research | Drug therapy | Cancer | Fees & charges | Kidneys | Stock options | PD-1 protein | Laboratories | Toxicity | Tumor cells | Body weight | Lung cancer | Colorectal carcinoma | Colorectal cancer | Melanoma | Licenses | Lymphocytes T | Patients | Castration | PD-L1 protein | Antitumor activity | Prostate cancer | Drug dosages | Prostate | Clear cell-type renal cell carcinoma | Tumors | Apoptosis | Index Medicus | Abridged Index Medicus
Journal Article
Cancer Cell, ISSN 1535-6108, 09/2015, Volume 28, Issue 3, pp. 285 - 295
Journal Article